[Retracted] Synergistic Effect of Stereotactic Radiotherapy Combined with Karelizumab on Patients with Advanced NSCLC

Table 5

Comparison of adverse reactions between two groups (n, %).

Groups	Fatigue	Diarrhea	Itchy skin	Thrombocytopenia	Neutropenia	Total incidence
Control group (n = 54)	7 (12.96%)	3 (5.56%)	1 (1.85%)	1 (1.85%)	0 (0.00%)	12 (22.22%)
Observation group (n = 46)	8 (17.39%)	2 (4.35%)	0 (0.00%)	3 (6.52%)	1 (2.17%)	14 (30.43%)
χ^2						0.870
value						0.350